124 related articles for article (PubMed ID: 7534194)
1. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1994 Dec; 666(1):147-50. PubMed ID: 7534194
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1995 May; 679(2):200-4. PubMed ID: 7543354
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
Ohno M; Watanabe S
Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
[TBL] [Abstract][Full Text] [Related]
4. Effect of no synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):831-8. PubMed ID: 9278954
[TBL] [Abstract][Full Text] [Related]
5. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
Inoue H; Arai I; Shibata S; Watanabe S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
7. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA.
Babbedge RC; Hart SL; Moore PK
J Pharm Pharmacol; 1993 Jan; 45(1):77-9. PubMed ID: 7679442
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine.
Stewart J; Deschamps SE; Amir S
Brain Res; 1994 Mar; 641(1):141-4. PubMed ID: 7517333
[TBL] [Abstract][Full Text] [Related]
9. Endogenous nitric oxide modulates behavioural effects elicited by substance P in rat.
Mancuso F; Calignano A; Sorrentino L
Eur J Pharmacol; 1994 Dec; 271(2-3):329-33. PubMed ID: 7535705
[TBL] [Abstract][Full Text] [Related]
10. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats.
Sandi C; Venero C; Guaza C
Eur J Pharmacol; 1995 Apr; 277(1):89-97. PubMed ID: 7543413
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthesis attenuates alcohol consumption in two strains of alcohol-preferring rats.
Rezvani AH; Grady DR; Peek AE; Pucilowski O
Pharmacol Biochem Behav; 1995 Feb; 50(2):265-70. PubMed ID: 7537886
[TBL] [Abstract][Full Text] [Related]
12. NG-nitro-L-arginine methyl ester modulates intestinal secretion and motility produced by carbachol.
Izzo AA; Mascolo N; Di Carlo G; Capasso F
Eur J Pharmacol; 1994 Dec; 271(1):31-5. PubMed ID: 7535232
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats.
Takeuchi K; Ohuchi T; Miyake H; Niki S; Okabe S
Eur J Pharmacol; 1993 Jan; 231(1):135-8. PubMed ID: 7680316
[TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
Panagiotidis G; Akesson B; Rydell EL; Lundquist I
Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613
[TBL] [Abstract][Full Text] [Related]
15. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
Laszlo F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
[TBL] [Abstract][Full Text] [Related]
17. Cerebral blood flow changes during cortical spreading depression are not altered by inhibition of nitric oxide synthesis.
Zhang ZG; Chopp M; Maynard KI; Moskowitz MA
J Cereb Blood Flow Metab; 1994 Nov; 14(6):939-43. PubMed ID: 7523432
[TBL] [Abstract][Full Text] [Related]
18. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
Honoré P; Chapman V; Buritova J; Besson JM
Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
[TBL] [Abstract][Full Text] [Related]
19. Stimulation by nitric oxide synthase inhibitors of gastric and duodenal HCO3- secretion in rats.
Takeuchi K; Ohuchi T; Miyake H; Okabe S
J Pharmacol Exp Ther; 1993 Sep; 266(3):1512-9. PubMed ID: 7690403
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
Kimes AS; Vaupel DB; London ED
Psychopharmacology (Berl); 1993; 112(4):521-4. PubMed ID: 7532866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
